ESC 365 - Novel TNNI3K variant is recurrently identified in Slovenian patients with cardiomyopathy and arrhythmias

HFA Premium Access

Novel TNNI3K variant is recurrently identified in Slovenian patients with cardiomyopathy and arrhythmias

Session: Pathophysiology and mechanisms

Topic: Genetics, Epigenetics, ncRNA

Speaker: Ms N. Vodnjov (Ljubljana, SI)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Ms Nina Vodnjov

University Clinical Centre Ljubljana, Ljubljana (Slovenia)

0 follower

5 more presentations in this session

Clinical burden of obstructive and non-obstructive hypertrophic cardiomyopathy: insights from a nationwide study in France

Speaker: Professor J. Trochu (Nantes, FR)

Neprilysin as a heart failure biomarker: addressing challenges and exploring new directions

Speaker: Mr T. Pinter (Debrecen, HU)

Impact of deleting MuRF1 or MuRF2 on the myocardium - male vs. female

Speaker: Doctor A. Schauer (Dresden, DE)

A modular, compact, portable hybrid cardiovascular system simulator for research and educational purposes

Speaker: Ms S. Ozcelik (Istanbul, TR)

Investigating renal pathology in transgenic experimental rats: unraveling the effects of hypertension and heart failure

Speaker: Doctor K. Andelova (Bratislava, SK)

Access the full session

Pathophysiology and mechanisms

Speakers: Ms N. Vodnjov, Professor J. Trochu, Mr T. Pinter, Doctor A. Schauer, Ms S. Ozcelik...

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources